Corvus Pharmaceuticals market cap CRVS
Share price times shares outstanding: what the whole company sells for, since 2016.
- Today, Nov 2, 2026
- $816M
- Highest close in our data
- $1.9B
- Jan 2026
Corvus Pharmaceuticals is worth $816M at the close on Nov 2, 2026, at $9.70 a share.
That is up 44% over the last year and up 251% over five years.
Its highest close in our data was $1.9B in Jan 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $816M | $507.1M | $1.9B | +42% |
| 2025 | $575.1M | $194.2M | $684.8M | +72% |
| 2024 | $334.8M | $68.7M | $591.1M | +288% |
| 2023 | $86.3M | $30.3M | $166.7M | +118% |
| 2022 | $39.6M | $34.4M | $104.7M | −65% |
| 2021 | $112.2M | $80.1M | $288.5M | +12% |
| 2020 | $99.9M | $58.9M | $170.8M | −23% |
| 2019 | $130.3M | $77.6M | $190.6M | +23% |
| 2018 | $105.7M | $105.7M | $384.8M | −52% |
| 2017 | $218M | $195.7M | $437.5M | −27% |
| 2016 | $299M | $217.5M | $348.8M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Corvus Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| CRVSCorvus Pharmaceuticals | $816M |
| ABUSArbutus Biopharma | $791.4M |
| COLLCollegium Pharmaceutical | $770.9M |
| ZVRAZevra Therapeutics | $599.8M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| IRWDIronwood Pharmaceuticals | $571.7M |
| PBYIPuma Biotechnology | $525.5M |
| OMEROmeros | $1.3B |
| ARVNArvinas | $491.7M |
| ANABAnaptysbio | $1.4B |
| PCRXPacira BioSciences | $1.5B |
| Peer median | $781.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Corvus Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.